The most relevant results of our study are: (i) CD8 T cells were increased at diagnosis of CLL, and the relative number of CD8 T cells at diagnosis was associated with the clinical outcome of the patients. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.